Development of a modified RNA circularization system to improve circRNA-based protein expression in mammalian cells
- ↵* Corresponding author; email: suncaijun{at}mail.sysu.edu.cn
Abstract
Circular RNA (circRNA) is emerging as a highly promising technology in various biomedical applications, offering advantages over traditional linear RNA. The Tornado (Twister-optimized RNA for durable overexpression) system has been widely investigated for generating circRNAs in mammalian cells; however, the use of Tornado system for large RNA inserts, especially those containing IRES sequences, is hindered by low circularization efficiency and limited circRNA abundance. Therefore, developing novel strategies to enhance RNA circularization in cells is of critical importance. In this study, we present a modified Tornado system that significantly improves circRNA-based protein expression by incorporating an optimal distance between the internal ribosome entry site (IRES) and the upstream CMV promoter. Furthermore, we elucidated the dual roles of HRV-B3 IRES in mammalian cells, demonstrating its negative regulatory effect on RNA abundance and its positive contribution to RNA circularization. Additionally, the integration of a truncated 5’ long terminal repeat (LTR) from HIV-1 upstream of the HRV-B3 IRES, combined with the woodchuck hepatitis virus posttranscriptional regulatory element (WPRE), further enhanced transcriptional efficiency in the Tornado system. This modified system holds great potential for advancing circRNA-based therapeutics and vaccines, and these findings provide valuable insights for refining the Tornado system and designing regulatory elements in synthetic biology applications.
Keywords
- Received August 20, 2025.
- Accepted August 28, 2025.
- Published by Cold Spring Harbor Laboratory Press for the RNA Society
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml). After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.










